Casticin induces breast cancer cell apoptosis by inhibiting the expression of forkhead box protein M1

Oncology Letters

Volumn 7, Issue 5, 2014, Pages 1711-1717

  Liu, Li Ping ^a   Cao, Xiao Cheng ^b   Liu, Fei ^b   Quan, Mei Fang ^b   Sheng, Xi Feng ^b   Ren, Kai Qun ^b  

^a HUNAN CANCER HOSPITAL   (China)

^b HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Breast cancer; Casticin; Forkhead box O3; Forkhead box protein M1; Therapeutic targets

Indexed keywords

CASTICIN; FLAVONOL; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXM1; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; BREAST CANCER; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; WESTERN BLOTTING;

EID: 84896302888     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1911     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 56: 106-130, 2006.
2. Kelsey JL, Gammon MD and John EM: Reproductive factors and breast cancer. Epidemiol Rev 15: 36-47, 1993.
3. Hulka BS and Stark AT: Breast cancer: cause and prevention. Lancet 346: 883-887, 1995.
4. Kelsey JL and Bernstein L: Epidemiology and prevention of breast cancer. Annu Rev Public Health 17: 47-67, 1996.
5. Fisher B, Costantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371-1388, 1998.
6. Cuzick J, Forbes J, Edwards R, et al: First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 360: 817-824, 2002.
7. Newman DJ, Cragg GM and Snader KM: Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66: 1022-1037, 2003.
8. Zeng X, Fang Z, Wu Y and Zhang H: Chemical constituents of the fruits of Vitex trifolia L. Zhongguo Zhong Yao Za Zhi 21: 167-168, 191, 1996 (In Chinese).
9. Haïdara K, Zamir L, Shi QW and Batist G: The flavonoid Casticin has multiple mechanisms of tumor cytotoxicity action. Cancer Lett 242: 180-190, 2006.
10. Weisskopf M, Schaffner W, Jundt G, Sulser T, Wyler S and Tullberg-Reinert H: A Vitex agnus-castus extract inhibits cell growth and induces apoptosis in prostate epithelial cell lines. Planta Med 71: 910-916, 2005.
11. Koh DJ, Ahn HS, Chung HS, et al: Inhibitory effects of casticin on migration of eosinophil and expression of chemokines and adhesion molecules in A549 lung epithelial cells via NF-kappaB inactivation. J Ethnopharmacol 136: 399-405, 2011.
12. Imai M, Kikuchi H, Denda T, Ohyama K, Hirobe C and Toyoda H: Cytotoxic effects of flavonoids against a human colon cancer derived cell line, COLO 201: a potential natural anti-cancer substance. Cancer Lett 276: 74-80, 2009.
13. Shen JK, Du HP, Yang M, Wang YG and Jin J: Casticin induces leukemic cell death through apoptosis and mitotic catastrophe. Ann Hematol 88: 743-752, 2009.
14. Chen D, Cao J, Tian L, Liu F and Sheng X: Induction of apoptosis by casticin in cervical cancer cells through reactive oxygen species-mediated mitochondrial signaling pathways. Oncol Rep 26: 1287-1294, 2011.
15. Zeng F, Tian L, Liu F, Cao J, Quan M and Sheng X: Induction of apoptosis by casticin in cervical cancer cells: reactive oxygen species-dependent sustained activation of Jun N-terminal kinase. Acta Biochim Biophys Sin (Shanghai) 44: 442-449, 2012.
16. Yang J, Yang Y, Tian L, Sheng XF, Liu F and Cao JG: Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells. World J Gastroenterol 17: 4298-4307, 2011.
17. Myatt SS and Lam EW: The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 7: 847-859, 2007.
18. Kops GJ, Medema RH, Glassford J, et al: Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol 22: 2025-2036, 2002.
19. Sunters A, Fernández de Mattos S, Stahl M, et al: FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem 278: 49795-49805, 2003.
20. Krol J, Francis RE, Albergaria A, et al: The transcription factor FOXO3a is a crucial cellular target of gefitinib (Iressa) in breast cancer cells. Mol Cancer Ther 6: 3169-3179, 2007.
21. Essafi A, Fernández de Mattos S, Hassen YA, et al: Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 24: 2317-2329, 2005.
22. Yang XH, Zheng X, Cao JG, Xiang HL, Liu F and Lv Y: 8-Bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK. World J Gastroenterol 16: 3385-3393, 2010.
23. Hollestelle A, Elstrodt F, Nagel JH, Kallemeijn WW and Schutte M: Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines. Mol Cancer Res 5: 195-201, 2007.
24. Wang Z, Ahmad A, Li Y, Banerjee S, Kong D and Sarkar FH: Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treat Rev 36: 151-156, 2010.
25. Wang Z, Banerjee S, Kong D, Li Y and Sarkar FH: Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res 67: 8293-8300, 2007.
26. Li Y, Wang Z, Kong D, Li R, Sarkar SH and Sarkar FH: Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. J Biol Chem 283: 27707-27716, 2008.
27. Chen Q, Ganapathy S, Singh KP, Shankar S and Srivastava RK: Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. PloS One 5: e15288, 2010.
28. Roy SK, Chen Q, Fu J, Shankar S and Srivastava RK: Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PloS One 6: e25166, 2011.
29. Kalinichenko VV, Major ML, Wang X, et al: Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev 18: 830-850, 2004.
30. Zanella F, Link W and Carnero A: Understanding FOXO, new views on old transcription factors. Curr Cancer Drug Targets 10: 135-146, 2010.
31. Sun Y, Zhao S, Tian H, et al: Depletion of PI3K p85alpha induces cell cycle arrest and apoptosis in colorectal cancer cells. Oncol Rep 22: 1435-1441, 2009.
32. Barreyro FJ, Kobayashi S, Bronk SF, Werneburg NW, Malhi H and Gores GJ: Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis. J Biol Chem 282: 27141-27154, 2007.
33. Lynch RL, Konicek BW, McNulty AM, et al: The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation. Mol Cancer Res 3: 163-169, 2005.
34. Davis R, Singh KP, Kurzrock R and Shankar S: Sulforaphane inhibits angiogenesis through activation of FOXO transcription factors. Oncol Rep 22: 1473-1478, 2009.
35. Shankar S, Chen Q and Srivastava RK: Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor. J Mol Signal 3: 7, 2008.
36. Zhao X, Ogunwobi OO and Liu C: Survivin inhibition is critical for Bcl-2 inhibitor-induced apoptosis in hepatocellular carcinoma cells. PloS One 6: e21980, 2011.
37. Huang H and Tindall DJ: Dynamic FoxO transcription factors. J Cell Sci 120: 2479-2487, 2007.